Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Finn

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
American Journal of Clinical Oncology|August 1, 1991
Ondansetron (GR 38032F): a novel antiemetic effective in patients receiving a multiple-day regimen of cisplatin chemotherapyJ D Hainsworth, G A Omura, A Khojasteh, et al.
British Journal of Clinical Pharmacology|November 1, 1981
Lignocaine disposition in blood in epilepsyP A Routledge, W W Stargel, A L Finn, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1992
Prostaglandins and systolic blood pressure, but not angiotensin II, independently affect atrial natriuretic peptide levels in manS A Klemm, R D Gordon, T J Tunny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinomaR Amato, C Meyers, J Ellerhorst, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1992
Subpressor calcium infusion increases isovolumic left ventricular relaxation time and atrial natriuretic peptide in humansW L Finn, R D Gordon, B I Seneviratne, et al.
Clinical and Experimental Pharmacology & Physiology|March 1, 1990
Suppressor calcium infusion raises plasma atrial natriuretic peptide concentrations in humansW L Finn, T J Tunny, S A Klemm, et al.
Clinical and Experimental Pharmacology & Physiology|April 1, 1988
Effects of volume expansion and contraction on plasma levels of atrial natriuretic peptide in manW L Finn, R D Gordon, T J Tunny, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1992
Inappropriately elevated levels of atrial natriuretic peptide may contribute to the pathophysiology of orthostatic hypotensionT J Tunny, R D Gordon, S A Klemm, et al.
American Journal of Respiratory and Critical Care Medicine|December 9, 2000
Sleep fragmentation, awake blood pressure, and sleep-disordered breathing in a population-based studyM J Morrell, L Finn, H Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trialK Fizazi, K A Do, X Wang, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
American Journal of Clinical Oncology|August 1, 1991
Ondansetron (GR 38032F): a novel antiemetic effective in patients receiving a multiple-day regimen of cisplatin chemotherapyJ D Hainsworth, G A Omura, A Khojasteh, et al.
British Journal of Clinical Pharmacology|November 1, 1981
Lignocaine disposition in blood in epilepsyP A Routledge, W W Stargel, A L Finn, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1992
Prostaglandins and systolic blood pressure, but not angiotensin II, independently affect atrial natriuretic peptide levels in manS A Klemm, R D Gordon, T J Tunny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinomaR Amato, C Meyers, J Ellerhorst, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1992
Subpressor calcium infusion increases isovolumic left ventricular relaxation time and atrial natriuretic peptide in humansW L Finn, R D Gordon, B I Seneviratne, et al.
Clinical and Experimental Pharmacology & Physiology|March 1, 1990
Suppressor calcium infusion raises plasma atrial natriuretic peptide concentrations in humansW L Finn, T J Tunny, S A Klemm, et al.
Clinical and Experimental Pharmacology & Physiology|April 1, 1988
Effects of volume expansion and contraction on plasma levels of atrial natriuretic peptide in manW L Finn, R D Gordon, T J Tunny, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1992
Inappropriately elevated levels of atrial natriuretic peptide may contribute to the pathophysiology of orthostatic hypotensionT J Tunny, R D Gordon, S A Klemm, et al.
American Journal of Respiratory and Critical Care Medicine|December 9, 2000
Sleep fragmentation, awake blood pressure, and sleep-disordered breathing in a population-based studyM J Morrell, L Finn, H Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trialK Fizazi, K A Do, X Wang, et al.
Pageof 18